Government-Use License and Stem Cell-Based Pharmaceuticals Patent : Equitabla Access to Covid-19 Medication

• Main Author: Mas Rahmah, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Universidad Del Zulia, Maracaibo-Venezuela 2020
• Subjects: K Law; K Law (General)
• Online Access: https://repository.unair.ac.id/112118/1/3b.%20Reviewer_Government-Use%20License.pdf; https://repository.unair.ac.id/112118/2/3.%20Government%20Use%20License%20and%20Steam%20Cell-Based%20Pharmaceuticals%20Patent_%20Equitable%20Access%20to%20Covid-19%20Medications.pdf; https://repository.unair.ac.id/112118/3/3a.%20TURNIITIN_Government-Use%20License%20and%20Stem%20Cell-Based%20Pharmaceuticals%20Patent-%20Equitable%20Access%20to%20Covid-19%20Medications-2%20%281%29.pdf; https://repository.unair.ac.id/112118/4/3C.%20KORESPONDENSI%20GOVERNMENT%20USE%20LICENSE....pdf; https://repository.unair.ac.id/112118/; https://produccioncientificaluz.org/index.php/utopia/article/view/33675; http://doi.org/10.5281/zenodo.4009611
• Institution: Universitas Airlangga

In response to the outbreak of the Covid-19 pandemic, some pharmaceutical companies have patented their drugs to combat it, including those based on stem cells. Questions about how to access such drugs will likely be raised because patent protection grants an exclusive right to the patent owner, to...